covid-19 vaccine update pfizer - Yahoo Search Results

Ads
related to: covid-19 vaccine update pfizer
Visit VaxAssist.com - 65 & Older Vaccine Eligibility

www.vaxassist.com/vaccine-finder
65 And Older & Got A 2023-24 COVID-19 Shot? You May Be Eligible For An Additional Dose. Use The Vaccine Finder To Find COVID-19 Vax Locations Near You & Help Stay Protected.
Schedule A Vaccine
Book A Vaccine Appointment

Today At A Location Near You.

Take Eligibility Quiz
Check Your Eligibility For Vaccines

That May Help Protect You.

Pneumococcal Pneumonia
Visit VaxAssist.com To

See If You Are Eligible.

Questions About Cost?
Visit To Find More Information

On COVID-19 Vaccination Costs.
Latest Updates About COVID-19 - Info On The New COVID Vaccine

www.aarp.org/covid-vaccine
Updated Coronavirus Information About Recommendations, Resources, And Latest Studies. 5 Things to Know About The New COVID-19 Vaccines - Learn More Now.

Search results

- Pfizer says tweaked COVID-19 shots boost omicron protection
  KRGV Rio Grande Valley· 4 days ago
  Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
- COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
  Reuters· 2 hours ago
  Vaccine makers should consider targeting one of the currently dominant JN.1 variants and...
- COVID Shots Could Use Another Update, Study Suggests
  MedPage Today· 5 days ago
  The updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the ...
- Is Pfizer the Best Dividend Stock for You?
  The Motley Fool via AOL· 2 days ago
  * Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
- Current COVID boosters offer good protection against severe outcomes but less so against JN.1
  Center for Infectious Disease Research and Policy· 4 days ago
  The current COVID-19 boosters targeting the Omicron XBB.1.5 subvariant are still... against...
- 2 Beaten-Down Dividend Stocks Near 52-Week Lows. Should You Buy the Dips?
  Motley Fool via Yahoo Finance· 6 days ago
  The Stock Advisor service has more than quadrupled the return...Renauer has no position in any of...
- Moderna’s vaccine for RSV gets FDA approval for people 60 and older - The Boston Globe
  The Boston Globe· 3 days ago
  Moderna said Friday that US drug regulators have approved its second product, a vaccine for...
- 3 Dividend Stocks to Double Up on Right Now
  Motley Fool via Yahoo Finance· 4 days ago
  Pfizer Once-booming COVID-19 vaccine sales have plunged, dragging down Pfizer's (NYSE: PFE) overall ...
- Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
  Bloomberg· 3 days ago
  Moderna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
- Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount
  InvestorPlace· 1 day ago
  For instance, management teams can focus too much on new projects or business lines that ultimately...